Age and Fertility: Understanding the Biological Clock and Your Conception Options
Of all the factors that influence human fertility, age is the one that is least modifiable and most misunderstood. Conversations about age and fertility are too often dominated by either excessive alarm — suggesting that fertility effectively ends at 35 — or wishful minimisation, asserting that modern medicine can overcome virtually any age-related challenge. The scientific reality is more nuanced and, for most people, more hopeful than either extreme suggests.
This guide examines the relationship between age and fertility with the rigour it deserves: what actually happens to egg and sperm quality and quantity over time, at what pace, and what evidence-based interventions can meaningfully preserve and support reproductive function at every stage of life.
Female Fertility and Age: The Biology
Female fertility is uniquely tied to age because women are born with their complete lifetime supply of eggs — approximately one to two million primordial follicles at birth. These follicles cannot be replenished. From birth, follicles are continuously lost through a process called atresia — the vast majority die without ever reaching maturation. By puberty, approximately 300,000 to 500,000 follicles remain; by the early 30s, around 50,000; and by menopause, the pool is essentially exhausted.
But the decline in fertility with age is not merely about egg quantity — it is equally about egg quality. As women age, the process by which eggs divide — meiosis — becomes increasingly error-prone. The spindle apparatus that separates chromosomes during cell division becomes less reliable, leading to more eggs with chromosomal abnormalities (aneuploidy). By age 35, approximately 30 to 40% of eggs may be aneuploid; by 40, this rises to 50 to 70%; and by 44 to 45, the majority of eggs may be chromosomally abnormal.
Aneuploid eggs either fail to fertilise, fail to implant, or result in early miscarriage (when the chromosomally abnormal embryo is naturally eliminated). This explains the age-related increases in time to pregnancy, IVF failure rates, and particularly miscarriage rates — which rise from approximately 10 to 15% in women under 35 to over 50% in women over 45.
Optimise Your Body for Conception
Conceive Plus Women's Fertility Support provides the evidence-based nutrients your body needs for healthy ovulation and egg quality — including methylfolate, myo-inositol, CoQ10, vitamin D3, and zinc.
How Fertility Actually Declines: A Realistic Timeline
The common narrative of a fertility "cliff at 35" is a significant oversimplification. Fertility declines continuously and gradually from the mid-20s — there is no sudden transition. The 35-year age threshold is a statistical risk category used in obstetrics (the "advanced maternal age" definition), not a biological tipping point. Understanding the realistic timeline helps people make informed decisions:
Early 20s: Peak fertility. Highest egg quality, lowest aneuploidy rates, fastest time to pregnancy. Monthly probability of conception (fecundability rate) in a fertile couple: approximately 20 to 25%.
Late 20s: Fertility remains high. A small, gradual decline in fecundability begins, but the majority of women have no difficulty conceiving. Monthly fecundability: approximately 18 to 22%.
Early 30s (30 to 34): Fertility remains good for most women. The decline accelerates slightly but is not dramatic for individuals in this age range. Monthly fecundability: approximately 15 to 18%. Cumulative 12-month pregnancy rates remain above 85% for most couples.
Mid-30s (35 to 39): The decline becomes more significant. Monthly fecundability falls to approximately 10 to 15%. Time to conception extends. The probability of chromosomal abnormalities in eggs rises more steeply. Miscarriage rates begin to increase. Many couples will still conceive naturally, but the proportion experiencing difficulty increases.
Early 40s (40 to 44): A more substantial decline. Monthly fecundability falls to approximately 5 to 10% or less. IVF success rates fall significantly. Miscarriage rates rise sharply. Natural conception remains possible for many women — births to women over 40 are increasing in all developed countries — but the challenges are substantially greater.
Mid-40s (45+): Natural conception is possible but uncommon. The vast majority of eggs at this age are chromosomally abnormal. IVF with own eggs has very low success rates, and most clinics will recommend donor eggs for women over 44 or 45 seeking assisted conception.
Ovarian Reserve Testing: Understanding Your Individual Timeline
Because the rate of ovarian decline varies significantly between individuals — some women have much higher or lower reserves than average for their age — ovarian reserve testing provides a personalised assessment of where a woman sits relative to her peers:
AMH (Anti-Müllerian hormone): Produced by the granulosa cells surrounding small antral follicles, AMH is the most reliable marker of ovarian reserve. It remains relatively stable throughout the cycle and can be measured from a single blood sample on any cycle day. Low AMH for age suggests diminished ovarian reserve; high AMH suggests high reserve (as in PCOS). AMH does not directly predict egg quality or pregnancy rates, but it provides important context for decision-making about conception timing and assisted reproduction.
Antral follicle count (AFC): A transvaginal ultrasound count of small (2 to 10 mm) antral follicles visible in both ovaries at the start of a cycle. AFC directly reflects the pool of follicles available for recruitment in that cycle and correlates closely with AMH. It is used in IVF planning to predict ovarian response to stimulation.
Day 3 FSH: Elevated FSH (above 10 to 12 IU/L) at cycle day 3 indicates impaired negative feedback from the ovaries on pituitary FSH secretion — a sign of reduced ovarian reserve. FSH is more variable than AMH and can be normal even with diminished reserve if inhibin B remains sufficient.
Importantly, these tests measure egg quantity, not egg quality — the factor that most determines age-related fertility decline. A woman with good AMH for her age still faces the same age-related aneuploidy risks as peers with lower AMH.
Egg Freezing: Fertility Preservation for Future Use
Egg freezing (oocyte vitrification) allows women to preserve eggs at a younger age for potential use in IVF later. Success rates from frozen eggs are highest when eggs are retrieved before age 35 — the ACOG and ESHRE recommend egg freezing before 38 for maximum effectiveness.
Modern vitrification (rapid freezing) technology has dramatically improved outcomes compared to the slow-freeze methods used before 2012. Current survival rates for vitrified eggs are over 80%, with fertilisation rates comparable to fresh eggs. Cumulative live birth rates per egg retrieved are higher than many people assume, though the number of eggs needed for a reasonable chance of live birth makes timing important: a 34-year-old may need 15 to 20 eggs retrieved for a reasonable (50 to 70%) chance of one live birth; a 38-year-old may need significantly more.
Egg freezing does not guarantee a future pregnancy but does preserve the option. For women who are not in a position to conceive now but wish to have the option later, it is a meaningful investment when done at an appropriate age.
A Complete Fertility Support System for Both Partners
When both partners optimise their nutrition, conception chances improve significantly. Conceive Plus offers a complete range of scientifically formulated fertility supplements for women and men — plus our fertility-friendly lubricant.
Male Fertility and Age
Male fertility also declines with age, but more gradually and less dramatically than female fertility. Men continue to produce new sperm throughout their lives — unlike women, who have a fixed egg supply. However, the quality of sperm production does diminish progressively from the mid-30s:
Sperm parameters: Sperm volume, count, motility, and morphology all decline gradually with age, typically from the mid-30s onward. The decline is modest at first but becomes more meaningful from age 45 to 50.
Sperm DNA fragmentation: The most clinically significant age-related change in sperm. DNA fragmentation — breaks and damage in the genetic material carried by sperm — increases progressively with age. Elevated DNA fragmentation in older men is associated with higher miscarriage rates even when the female partner is young, and with reduced IVF success rates. Antioxidant supplementation has the strongest evidence for reducing DNA fragmentation.
De novo mutations: The risk of de novo (new, not inherited) mutations in sperm increases with paternal age. This is the mechanism behind the well-documented associations between advanced paternal age (typically defined as 40 to 45+) and slightly increased risks of conditions including autism spectrum disorder, schizophrenia, and certain cancers in offspring. The absolute risk remains low, but the association is real and should be contextualised in conversations about delayed paternity.
Testosterone decline: Testosterone declines at approximately 1 to 2% per year from the early 30s (late-onset hypogonadism). This affects libido, energy, and to some extent sperm quality. CoQ10, zinc, and vitamin D have evidence for supporting testosterone levels in ageing men.
Nutrition and Supplements to Support Fertility With Age
While nutritional intervention cannot reverse the age-related aneuploidy that is the primary driver of age-related fertility decline, it can meaningfully support the aspects of egg and sperm quality that are modifiable:
CoQ10: Has the strongest evidence for supporting egg mitochondrial function in older women. Mitochondria are the energy source that powers the chromosomal segregation process during egg maturation — the very process that becomes error-prone with age. While CoQ10 cannot directly repair chromosomally abnormal eggs, it supports the mitochondrial environment in which eggs are developing and may reduce the proportion of eggs affected by mitochondrial dysfunction-related aneuploidy. Doses used in fertility research: 400 to 600 mg/day of ubiquinol for women.
Methylfolate (5-MTHF): Essential for DNA synthesis in developing eggs and the earliest stages of embryo development. The active form is particularly important for women with MTHFR variants. Recommended for all women trying to conceive at any age.
DHEA (dehydroepiandrosterone): Produced by the adrenal glands, DHEA is a precursor to androgens and oestrogens in the ovarian follicle. Declining DHEA levels with age are associated with falling androgen levels in the ovarian microenvironment. Randomised trials have found that DHEA supplementation (typically 25 to 75 mg/day) in women with diminished ovarian reserve improves ovarian response to IVF stimulation, egg quality, and pregnancy rates. DHEA should only be taken under medical supervision, as it can cause androgenic side effects and its effects on women with normal ovarian reserve are less well characterised.
Vitamin D: Essential for follicular development, egg maturation, and endometrial receptivity. Vitamin D deficiency is associated with lower AMH and worse IVF outcomes. Levels should be tested and deficiency corrected.
Melatonin: Increasingly used in IVF protocols for older women. Melatonin is a potent antioxidant that concentrates specifically in follicular fluid, protecting the developing egg from oxidative damage. Some IVF clinics routinely recommend melatonin for women over 38 undergoing IVF.
When to Seek Medical Evaluation: The Age-Adjusted Timelines
The standard guideline for seeking fertility evaluation is 12 months of regular unprotected intercourse without conception. However, this is adjusted based on age:
Under 35: Seek evaluation after 12 months of trying.
35 to 37: Seek evaluation after 6 months of trying.
38 to 39: Seek evaluation after 3 to 6 months of trying.
40 or over: Seek evaluation immediately — do not delay. Time is a significant variable at this age, and early consultation allows time for options to be explored and implemented.
These timelines are not absolute rules but practical guidelines. If there are known risk factors — prior pelvic surgery, irregular cycles, known male factor — evaluation should happen sooner regardless of age.
Frequently Asked Questions
Q: At what age does female fertility start declining?
Female fertility declines continuously and gradually from the mid-20s — there is no sudden cliff. The decline becomes more noticeable in the early to mid-30s and accelerates from the late 30s. The "35 threshold" is a statistical risk category in obstetrics, not a biological turning point. Most women in their early to mid-30s remain fertile.
Q: Can I improve egg quality at 38 or 40?
Egg quality is influenced by both the inherent chromosomal state of the egg (which deteriorates with age and cannot be reversed) and the mitochondrial and cellular environment in which the egg develops (which is modifiable through nutrition and supplements). CoQ10, vitamin D, antioxidants, and an anti-inflammatory diet support the latter, potentially reducing the proportion of developmentally impaired eggs among those that develop in any given cycle.
Q: What is diminished ovarian reserve and what can be done?
Diminished ovarian reserve (DOR) means a lower-than-expected egg supply for age, reflected in low AMH, low antral follicle count, or elevated day 3 FSH. It reduces the number of eggs available for conception in each cycle and often correlates with declining egg quality. Options include: CoQ10 and DHEA supplementation, moving to IVF to maximise the use of available eggs, or using donor eggs if the reserve is very low.
Q: Is 40 too old to try to conceive naturally?
No. Many women conceive naturally at 40 and beyond. Monthly conception rates are reduced (approximately 5 to 10%) and miscarriage rates are higher, but natural conception is achievable. If natural conception has not occurred after a few months of trying at 40, prompt evaluation and consideration of IVF (to work with the remaining eggs more efficiently) is appropriate.
Q: Does paternal age affect the baby?
Yes, to some extent. Advanced paternal age (typically from 40 to 45+) is associated with slightly increased risks of de novo mutations, and associated conditions including autism spectrum disorder and schizophrenia in offspring. The absolute risks remain low. Sperm DNA fragmentation increases with age and is associated with higher miscarriage rates even when the female partner is young.
Q: What is AMH and what does a low result mean?
AMH (anti-Müllerian hormone) is produced by small follicles in the ovaries and reflects the size of the remaining follicle pool (ovarian reserve). A low AMH for age suggests fewer available eggs — this makes natural conception less probable per cycle and IVF responses lower. However, AMH does not directly measure egg quality, and women with low AMH can and do conceive naturally and through IVF.
Q: Should I freeze my eggs?
Egg freezing is most effective when done before age 35 and loses effectiveness rapidly after 38. If you are not planning to try to conceive in the near future and are under 37 to 38, egg freezing is worth discussing with a fertility specialist. It preserves the option but does not guarantee future success — success rates vary with age at freezing and the number of eggs retrieved.
Q: Can supplements like CoQ10 reverse age-related egg quality decline?
No supplement can reverse chromosomal aging in eggs. However, CoQ10 — particularly at higher doses of 400 to 600 mg/day of ubiquinol — supports the mitochondrial environment in which eggs develop, potentially improving developmental competence in eggs that are not chromosomally impaired. Clinical evidence for CoQ10 improving IVF outcomes in older women is encouraging but not yet definitive.
Q: How does stress affect fertility as I get older?
Chronic stress at any age can suppress ovulatory function through cortisol's inhibitory effects on GnRH pulsatility. As women age and their reproductive window becomes more time-sensitive, the stress of trying to conceive can itself become a compounding factor. Managing stress — through mindfulness, CBT, appropriate exercise, and social support — is important both for quality of life and for maintaining optimal hormonal conditions for conception.
Q: When is it time to consider donor eggs?
Donor egg IVF is typically discussed when a woman's own eggs cannot reliably produce viable embryos — usually due to very low ovarian reserve, poor IVF response, or repeated failed cycles with chromosomally abnormal embryos. Most clinics begin discussing donor eggs for women over 43 to 45 with poor IVF outcomes, though this varies with individual circumstances and the woman's wishes.
Conclusion
Age and fertility is a topic that deserves honesty, nuance, and hope in equal measure. Yes, fertility declines with age — and the decline in egg quality, particularly from the late 30s, is real and significant. But the decline is gradual, highly individual, and not remotely as simple as any specific threshold suggests. Many women conceive naturally and successfully in their late 30s and early 40s; many more do so with targeted nutritional support and appropriate medical assistance.
The most powerful things any person can do to support fertility as they age are: understand their individual ovarian reserve, start evidence-based supplementation early (particularly CoQ10, methylfolate, and vitamin D), pursue evaluation sooner rather than later when conception is not occurring, and work with a specialist who can translate their individual hormone profile into a personalised strategy.
Time is a variable in fertility — but it is not the only variable. Consistent, well-informed action across nutrition, supplementation, and medical care gives every person the best possible foundation at every stage of their reproductive journey.
Optimise Your Body for Conception
Conceive Plus Women's Fertility Support provides the evidence-based nutrients your body needs for healthy ovulation and egg quality — including methylfolate, myo-inositol, CoQ10, vitamin D3, and zinc.
